Diagnosis of AML, not otherwise specified

  • A diagnosis of AML, not otherwise specified requires the presence of at least 20% of the specific leukaemia cells in the blood/bone marrow.
  • The immunophenotyping and genetic information available in this AML group can help the haematologist diagnose the precise type of AML.
  • Although immunophenotypes aren’t conclusive for making a diagnosis, they are useful to exclude other types of leukaemia in difficult cases.
  • More distinct subtypes in the AML, not otherwise specified group are
  • Acute megakaryoblastic leukaemia (AMKL)
  • Acute myelomonocytic leukaemia (AMML)
  • Details of these subtypes are available at shop.leukaemiacare.org.uk